Lifeboat Foundation

Wake Forest Institute for Regenerative Medicine (WFIRM) scientists have created a promising injectable cell therapy to treat osteoarthritis that both reduces inflammation and also regenerates articular cartilage.

Recently identified by the Food and Drug Administration as a public health crisis, osteoarthritis affects more than 520 million people worldwide who deal with pain and inflammation. Osteoarthritis is typically induced by mechanical or traumatic stress in the joint, leading to damaged cartilage that cannot be repaired naturally.

“Without better understanding of what drives the initiation and progression of osteoarthritis, effective treatment has been limited,” said lead author Johanna Bolander of WFIRM. “Initially, we studied what goes wrong in osteoarthritic joints, compared these processes to functional environments, and used this information to develop an immunotherapy cell treatment.”

Researchers discover a mechanism used by neurons to repair damage that occurs during neuronal activity.

😗

A new study shows that an FDA-approved, pharmaceutical-grade formulation of CBD has an antiviral effect in human lung cells and mice, and shows a significant negative association with COVID infection in human patients.

Donald Hoffman interview on spacetime, consciousness, and how biological fitness conceals reality. We discuss Nima Arkani-Hamed’s Amplituhedron, decorated permutations, evolution, and the unlimited intelligence.

The Amplituhedron is a static, monolithic, geometric object with many dimensions. Its volume codes for amplitudes of particle interactions & its structure codes for locality and unitarity. Decorated permutations are the deepest core from which the Amplituhedron gets its structure. There are no dynamics, they are monoliths as in 2001: A Space Odyssey.

Continue reading “Exposing the Strange Blueprint Behind ‘Reality’ (Donald Hoffman Interview)” »

Scientists in Britain have finally solved one of the greatest mysteries of life: how chromosomes get their X shape. Chromosomes, discovered in the late 1800s, are DNA molecules which contain the genetic material of an organism.

All chromosomes, without exception, either go through or end up with an X shape before the cells of an organism divide.

But it was always a mystery how they are X-shaped. While Biology students across the world study that chromosomes get their shape during cell division, the exact reason behind their X shape was not known.

Experts from Charles River and Valo Health describe how artificial intelligence will change the drug discovery landscape.

Small interfering RNAs (siRNAs) are novel therapeutics that can be used to treat a wide range of diseases. This has led to a growing demand for selective, efficient, and safe ways of delivering siRNA in cells. Now, in a cooperation between the Universities of Amsterdam and Leiden, researchers have developed dedicated molecular nanocages for siRNA delivery. In a paper just out in the journal Chem they present nanocages that are easy to prepare and display tunable siRNA delivery characteristics.

The nanocages were developed in the research group for Homogeneous, Supramolecular and Bio-inspired catalysis of Prof. Joost Reek and Bas de Bruin at the University of Amsterdam’s Van ‘t Hoff Institute for Molecular Sciences, and further studies in the group Prof. Alexander Kros at the Leiden Institute of Chemistry.

The researchers were motivated by the potential of siRNA in gene therapy, which requires the need for effective delivery systems. They set out to develop nanocages with functional groups at the outside, making the cages capable of binding siRNA strands. As the binding is based on reversible bonds, the siRNA can in principle be released in a cellular environment. To explore the delivery characteristics of their nanocages, the researchers performed a laboratory study using various human cancer cells.

Among the biggest environmental problems of our time, micro-and nanoplastic particles (MNPs) can enter the body in various ways, including through food. And now for the first time, research conducted at MedUni Vienna has shown how these minute particles manage to breach the blood-brain barrier and as a consequence penetrate the brain. The newly discovered mechanism provides the basis for further research to protect humans and the environment.

Published in the journal Nanomaterials, the study was carried out in an animal model with oral administration of MNPs, in this case polystyrene, a widely-used plastic which is also found in food packaging. Led by Lukas Kenner (Department of Pathology at MedUni Vienna and Department of Laboratory Animal Pathology at Vetmeduni) and Oldamur Hollóczki (Department of Physical Chemistry, University of Debrecen, Hungary) the research team was able to determine that tiny polystyrene particles could be detected in the brain just two hours after ingestion.

The mechanism that enabled them to breach the blood-brain barrier was previously unknown to medical science. “With the help of computer models, we discovered that a certain surface structure (biomolecular corona) was crucial in enabling plastic particles to pass into the brain,” Oldamur Hollóczki explained.

Could a vaccine for dealing with cholesterol be in the works? If clinical trials succeed, Vaxxinity’s new vaccine could be a game changer for this chronic medical condition.

Millions daily take statins to combat high cholesterol. But a vaccine that turns on the body’s natural immune response is in the works.